- Registration is now open!
-
To stay updated on the relevant developments, make sure you are signed up for our newsletter.
Meeting category
Date(s)
12 May 2025
Important dates
Early Registration Deadline
Tuesday, 14 January 2025
Abstract Submission Deadline
Friday, 14 February 2025
Program Language
English
Location
Windhoek,
Namibia
Meeting type
Live meeting
2nd Conference on Innovations in Tuberculosis 2025
General
What's New
About this Program
The Conference on Innovations in Tuberculosis 2025 is scheduled for 12 May 2025, in Windhoek, Namibia, as a pre-conference to the INTEREST 2025 Conference.
Tuberculosis (TB) caused 1.6 million deaths in 2021, making it the leading cause of death among infectious diseases, surpassing HIV. Yet, it is a curable and preventable disease. While a quarter of the global population has been infected, only 5-10% of infected individuals develop symptoms. The regions with the highest burden are South-East Asia, Africa, and the Western Pacific. This bacterial disease is treated with a long course of antibiotics. However, treatment options for Multidrug-resistant TB (MDR-TB) are limited, and MDR-TB remains a public health crisis and a health security threat.
TB is a priority on the global health agenda. The coordinated efforts of national and global leadership, research organizations, and civil society strive to achieve a world free of TB. However, equitable access to prevention, testing, treatment, and care remains a challenge. On the other hand, we are witnessing the emergence of encouraging new tools to curb TB. A recent study demonstrated a remarkable reduction in TB transmission due to nutritional supplements offered to household contacts, providing an evidence-based approach to addressing structural determinants of TB, such as malnutrition. On the biomedical side, a historic milestone appears to be within reach, with the late-stage clinical evaluation of a vaccine to prevent the pulmonary form of TB in adolescents and adults, developed by the Gates Foundation. In parallel, new treatment guidelines for 6-month all-oral regimens for MDR-TB offer simplified treatment options for these patients.
Despite these exciting developments and innovations, they are primarily discussed at major international meetings, which in turn offers limited opportunities for researchers and healthcare professionals from high-burden countries in Africa. This also restricts discussions tailored to regional epidemiological situations, healthcare, and societal contexts. Therefore, we propose a platform to disseminate clinically relevant innovations and discuss their translation and implementation in Africa, considering region-specific epidemic patterns, available prevention, testing, and treatment options, and healthcare settings.
Local Chairs
General Information
Uniques Features
• Plenary lectures
• Abstracts
• Poster-viewing sessions
• Capacity-building sessions
• Mentoring Sessions
• Roundtable discussions
• Pro-con debates
• Networking Opportunities
• Exhibition
• Abstracts
• Poster-viewing sessions
• Capacity-building sessions
• Mentoring Sessions
• Roundtable discussions
• Pro-con debates
• Networking Opportunities
• Exhibition
Who Should Attend?
• Clinical and translational researchers
• Epidemiologists and public health experts
• Program implementers
• (Non)Government representatives
• Health authorities
• Residents, and post-graduate students
• Advocates and community representatives
• Industry representatives
• Epidemiologists and public health experts
• Program implementers
• (Non)Government representatives
• Health authorities
• Residents, and post-graduate students
• Advocates and community representatives
• Industry representatives
Meeting Objectives
Our goal is to deliver a high-quality program on innovations in Tuberculosis with an emphasis on region-specific needs. We aim to provide a platform for scientific interchange, education, and fostering collaborations to advance the field. More specifically, the program is aimed to:
- Create an African dissemination platform for an unbiased, scientific exchange and education regarding clinically relevant advances in Tuberculosis;
- Provide educational settings to discuss the clinical translation of recent developments considering regional epidemic patterns and healthcare systems;
- Share real-world experience and facilitate evidence-based program implementation;
- Foster new and lasting cross-disciplinary collaborations aiming to strengthen Tuberculosis research and management in high-disease-burden regions;
- Encourage early-career investigators to actively participate in the program and support their career trajectory toward future leaders in Tuberculosis research.
- Create an African dissemination platform for an unbiased, scientific exchange and education regarding clinically relevant advances in Tuberculosis;
- Provide educational settings to discuss the clinical translation of recent developments considering regional epidemic patterns and healthcare systems;
- Share real-world experience and facilitate evidence-based program implementation;
- Foster new and lasting cross-disciplinary collaborations aiming to strengthen Tuberculosis research and management in high-disease-burden regions;
- Encourage early-career investigators to actively participate in the program and support their career trajectory toward future leaders in Tuberculosis research.
Practical Information
Venue
The venue will be announced closer to the Conference.
Accommodation
Accommodation is not included in the registration fee.
Badges
All participants are requested to wear the badge at all times during the conference to ensure admission to the meeting.
Certificate of Attendance
A certificate of attendance will be sent to you after successfully completing the program and post-conference survey.
Language
The official language of the conference is English
Translation will not be provided.
Translation will not be provided.
Enduring Materials
Enduring materials will be available to all registered delegates on the website 3 weeks after the conference. After this, all presentations will be made publicly available on this website (pending the approval of the speakers).
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Registration
Please note that payment by credit card is required to be able to register for the conference. Please contact the conference secretariat if this is not possible for you.
Registration is now open!
Fees and Conditions
|
Academia |
Industry |
RLS |
Local HCP |
|
|---|---|---|---|---|
|
Early Fee (payment before/on 14 January 2025) |
€355 |
€835 |
€90 |
€30 |
|
Regular Fee (payment from/on 14 January 2025) |
€535 |
€1075 |
€125 |
€40 |
|
Late Fee (payment from/on 14 March 2025) |
€595 |
€1195 |
€150 |
€50 |
|
Fee Waivers |
|
|---|---|
|
Early-Career Investigators / Academia from Resource-Limited Settings (RLS)* WITH accepted abstract |
50% Off Current Fee |
|
Early-Career Investigators and/or Academia from Resource-Limited Settings (RLS)* WITHOUT an accepted abstract |
50% Off Current Fee |
|
NGO Representatives / Government Representatives (i.e. MOH, NIH, NIAID, etc.) / Community Advocates |
50% Off Current Fee |
|
Members of Endorsers |
25% Off Current Fee |
|
Sponsors |
Contact Secretariat |
If you are eligible for a discount, please contact the conference secretariat Yulia Veldhuis at yulia.veldhuis@amededu.com for the special registration code.
*Countries included in the low-income and middle-income economies list of the World Bank Classification
Important
-
We strongly advise that you register early to ensure your registration. Registration will close when the capacity of the venue is reached.
-
Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.
Registration Fee Includes
For onsite attendees:
- Access to all scientific sessions, including poster area
- Conference pack, including abstract book and program
- Refreshments during the coffee breaks
- Buffet lunch on conference days
IMPORTANT:
- No day rate is available
- Payment can only be made by credit card.
- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
- Access to all scientific sessions, including poster area
- Conference pack, including abstract book and program
- Refreshments during the coffee breaks
- Buffet lunch on conference days
IMPORTANT:
- No day rate is available
- Payment can only be made by credit card.
- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
Group Registration
For registration of groups larger than 5 participants, please contact yulia.veldhuis@amededu.com to request registration through the Group Registration Portal.
Early-Career Investigators / Academia from Resource-limited Settings (RLS)
We are pleased to offer a lower registration fee for early-career investigators and academia from low-income and lower-middle-income countries.
To be eligible as an early-career investigator, one should either be a current Master/PhD student or have obtained an MD/PharmD/PhD degree in the last five years. An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least two weeks prior to the start of the workshop. Virology Education will contact the early-career investigator with instructions regarding the registration procedure.
To be eligible as an early-career investigator, one should either be a current Master/PhD student or have obtained an MD/PharmD/PhD degree in the last five years. An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least two weeks prior to the start of the workshop. Virology Education will contact the early-career investigator with instructions regarding the registration procedure.
Payment
By credit card only: online or by written authorization (see online registration).
Cancellation Policy
In case of cancellation, the following refunds are applicable:
- Cancellation before/on 12 April 2025: 50% refund (minus an administration fee of €40)
- Cancellation after 12 April 2025: Unfortunately, no refund will be given
If you are unable to attend the conference, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 28 April 2025. A statement (email/letter) of cancellation must be sent to Virology Education.
- Cancellation before/on 12 April 2025: 50% refund (minus an administration fee of €40)
- Cancellation after 12 April 2025: Unfortunately, no refund will be given
If you are unable to attend the conference, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 28 April 2025. A statement (email/letter) of cancellation must be sent to Virology Education.
Liability and Insurance
By registering for the conference, participants agree that the organizers do not accept responsibility for medical, travel, or personal insurance. Participants are advised to take out their own insurance policies.
Media Registration
In order to register as a media participant for the Conference, the conference secretariat needs to receive:
1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop
A complimentary or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.
We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.
Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2020 embargo policy.
1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop
A complimentary or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.
We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.
Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2020 embargo policy.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The organizing secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop. In case of cancellation of the meeting due to unforeseen circumstances, Virology Education cannot be held responsible for expenses made for travel, accommodation, visa applications, etc.
Program
The program for the Conference on Innovations in Tuberculosis 2025 is currently under development and subject to change.
The below times are set in Central Africa Time (CAT). Please, use this tool to convert the timing into your time zone.
Monday, 12 May 2024
Opening & Welcome - 8:30
8:30
Welome to the TB Conference
Session 1: Innovations in TB Diagnostics and Screening - Symtomatic and Asymptomatic TB - 9:15
9:15
Recent Developments in TB Testing and Screening Technologies, Including for HIV-associated TB and TB in Children
9:35
Abstract Driven Presentations
10:05
Panel Discussion: Pros and Cons of Novel Approaches to Tackle a Long-standing Enemy?
10:30
Coffee Break
Session 2: When Many Epidemics Collide: TB and Comorbidities - 11:00
11:00
Towards Integrated Prevention, Treatment, and Service Provision for TB, HIV and NCDs
11:20
Abstract Driven Presentations
Session 3: THE GREAT DEBATE: Should Africa Move to Whole Genome Sequencing for Drug Resistance Testing? - 12:00
12:00
PRO Standpoint
12:05
CON Standpoint
12:10
Discussion
12:30
Lunch
Session 4: TB Clinical Management: Advanced HIV - 13:30
13:30
TB meningitis / TB in advanced HIV
13:50
Abstract Driven Presentations
Session 5: "Thinking Big" Data-Driven Solutions for TB and HIV - 14:20
14:20
Flash Poster Presentations
14:40
Panel Discussion: How "Big Data" Can Enhance the Clinical Outcomes?
15:00
Coffee Break
Session 6: Post-TB Lung Disease - 15:30
15:30
Long-term Sequelae of TB
15:50
Abstract Driven Presentations
16:20
Discussion
16:50
Poster Viewing Gallery
18:00
Closing of the TB Conference
Abstracts
The Abstract Submission Portal is now open!
Deadline: Friday, 14 February 2025 at 23:59 CAT
Abstracts
- The Conference on Innovations in Tuberculosis accepts new original data as well as encored abstracts. All abstracts must focus on the African region and contain up-to-date information at the time of the conference.
- Early-career professionals and academia from Resource-Limited Settings with an accepted abstract will be offered a 50% discount on the Early Fee. The requirements for the application are specified here.
-
Abstract presenters are expected to attend the workshop in-person to present their abstract.
Please contact the workshop secretariat if this is not possible.
- Abstract submitters are strongly encouraged to use person-first language in their abstracts. View the video tutorial and guidelines here.
Terms and Conditions
By submitting an abstract to a meeting organized by Virology Education BV (VE), the abstract submitter hereby agrees to the terms and conditions.
The terms and conditions can be viewed here.
Categories for Abstract Submission
For purposes of review and programming, abstracts are divided into topical categories. The selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.
- TB Diagnostics
- Screening for symptomatic and/or asymptomatic TB
- TB-related comorbidities and coinfections
- TB clinical management, including in advanced HIV
- TB drug resistance
- Post-TB Lung Disease
- AI and Big Data in TB research and/or program implementation
- TB Diagnostics
- Screening for symptomatic and/or asymptomatic TB
- TB-related comorbidities and coinfections
- TB clinical management, including in advanced HIV
- TB drug resistance
- Post-TB Lung Disease
- AI and Big Data in TB research and/or program implementation
General Guidelines
Abstracts should contain the following four components:
- Background: A concise statement of the issue under investigation or a hypothesis;
- Material and Methods: The experimental methods used (including the statistical analyses employed);
- Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
- Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).
Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.
Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.
We encourage you to use person-first language in your abstract(s). View our guidelines here: https://academicmedicaleducation.com/person-first-language
- Background: A concise statement of the issue under investigation or a hypothesis;
- Material and Methods: The experimental methods used (including the statistical analyses employed);
- Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
- Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).
Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.
Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.
We encourage you to use person-first language in your abstract(s). View our guidelines here: https://academicmedicaleducation.com/person-first-language
Poster Presentation Instructions
Note: For In-person events, poster presenters are expected to attend onsite.
Posters need to meet the following dimensions A0 size (approx. 33" x 47") in portrait format.
Please display the number of your poster in the upper right corner of your poster.
Poster presenters are requested to stand near their posters during the poster session.
We advise you to prepare hand-outs of your poster on Letter or A4 format.
Please hang your posters as early as possible. All posters must be displayed from the opening session to the closure of the meeting.
Pushpins and/or velcro will be provided.
Posters need to meet the following dimensions A0 size (approx. 33" x 47") in portrait format.
Please display the number of your poster in the upper right corner of your poster.
Poster presenters are requested to stand near their posters during the poster session.
We advise you to prepare hand-outs of your poster on Letter or A4 format.
Please hang your posters as early as possible. All posters must be displayed from the opening session to the closure of the meeting.
Pushpins and/or velcro will be provided.
Committees
Local Chairs
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the conference, identify interesting topics and candidate speakers, and review all submitted abstracts.
The members of Scientific Committee are hand-picked by the Organizing Committee (OC) and the conference secretariat based on their significant contributions and commitment to the field. They assist the OC by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the conference as moderators and/or chairs of sessions.
- Amsalu Bekele Binegdie, MD, College of Health Sciences, Addis Ababa University, Ethiopia
- John Bimba, PhD, Bingham University, Nigeria
- Maryline Bonnet, MD, PhD, The French National Research Institute for Sustainable Development (IRD), the University of Montpellier and the National Institute of Health and Medical Research, Montpellier, France, Mbarara University of Science and Technology in MBarara, Uganda
- Jeremiah Chakaya Muhwa, MBChB, MMeD, DThM, Kenyatta University, Respiratory Society of Kenya, Kenya
- Novel Chegou, BMLS (Hons), BSc. Hons., PhD, Stellenbosch University, South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, South Africa
- Joel Fleury Djoba Siawaya, PhD, HDR, Mother and Child University Hospital, Gabon
- Thandi J.N Dlamini-Miti, MBBCh, Msc, Isango Lethemba TB Research Unit, Nakekelwa Medical Institute, South Africa
- Alberto García-Basteiro, MD, PhD, Barcelona Institute for Global Health (ISGlobal), Spain, Centro de Investigação em Saúde de Manhiça (CISM), Mozambique
- Norbert Heinrich, MD, LMU University Hospital, Germany
- Bouke de Jong, MD, PhD, Institute of Tropical Medicine, Belgium
- Celso Khosa, MD, PhD, Instituto Nacional de Saúde, Mozambique
- Andre Loxton, PhD, SAMRC and Stellenbosch University, South Africa
- Sayoki G Mfinanga, MD,PhD, Liverpool School Tropical Medicine, University Collage London, England, Nelson Mandela African Institution of Science and Technology (NM-AIST), The Muhimbili University of Health and Allied Sciences, Tanzania
- Lloyd Mulenga, BScHb, MBChB, MSc, MMed, PhD, Ministry of Health, Zambia
- Esther Stanslaus Ngadaya, MD, PGDHE, PhD, National Institute for Medical Research (NIMR), Kampala National University, Tanzania
- Abel Nkolo, MBChB, MPH, PhD, Africa and LAC Region, Uganda
- Nyanda Elias Ntinginya, MD, Msc, PhD, National Institute for Medical Research (NIMR), Tanzania
- Issa Sabi, MD, MMed, PhD, Mbeya Medical Research Center, National Institute for Medical Research (NIMR), Tanzania
- Simon Walusimbi, MD, MSc, PhD, Makerere University School of Public Health and Lung Institute, Uganda
Support
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and researchers interested in the Conference on Innovations in Tuberculosis.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause, get in touch with us for a tailored
support package by contacting Karin Siebelt at karin.siebelt@amededu.com.
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.
- Symposium opportunities
- Non-commercial interviews with company representatives
- Verbal acknowledgement during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
- Company acknowledgement on printed meeting materials including but not limited to banners and the program book
- Digital and printed advertising opportunities
- Social media shout-outs
- Logo on the conference bag
*Subject to the support level.
Previous Editions
Endorsers
The Conference on Innovations in Tuberculosis 2025 is endorsed by societies and organizations. Their support and collaboration are key to the success of this conference!
Members or employees of endorsing organizations are eligible for a 25% discount on the registration fee for academia. Please contact your organization to obtain the applicable discount code.
If you would like your organization to endorse this workshop, please contact Yulia Veldhuis at Yulia.Veldhuis@amededu.com
Endorsers
TBPeople Eswatini
Language
Related Programs
